Is COVID-19 infection more severe in kidney transplant recipients?
2020 · American Journal of Transplantation · 263 citations
https://doi.org/10.1111/ajt.16424
L
Lionel Couzi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
297
Papers
9.5K
Citations
51
h-index
140
i10-index
Lionel Couzi is an academic researcher from Centre National de la Recherche Scientifique. The author has contributed to research in topics: Renal Transplantation Outcomes and Treatments & Cytomegalovirus and herpesvirus research & Renal Diseases and Glomerulopathies. The author has an h-index of 51, co-authored 253 publications.
ORCID: 0000-0002-9213-6196Papers by this author
worksSafety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies
2019 · American Journal of Transplantation · 89 citations
https://doi.org/10.1111/ajt.15397
Microvascular Inflammation of Kidney Allografts and Clinical Outcomes
2024 · New England Journal of Medicine · 45 citations
https://doi.org/10.1056/nejmoa2408835
Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021
2022 · Transplant Infectious Disease · 42 citations
https://doi.org/10.1111/tid.13977
Early Administration of Anti–SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients
2022 · Kidney International Reports · 30 citations
https://doi.org/10.1016/j.ekir.2022.03.020
Intellectual disability in patients with MODY due to hepatocyte nuclear factor 1B (HNF1B) molecular defects
2016 · Diabetes & Metabolism · 27 citations
https://doi.org/10.1016/j.diabet.2016.10.003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat